Drug intelligence / Profile preview

zinc gluconate + glycine

Development stage
Unknown
Lead developer
Quigley Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Zinc gluconate + glycine** is a combination of zinc gluconate, a zinc salt, and glycine (aminoacetic acid), formulated as lozenges primarily for treating symptoms of the common cold. The zinc component provides an essential trace mineral that supports enzymatic reactions, immune function, protein synthesis, wound healing, and cell division; proposed antiviral mechanisms include inhibiting rhinovirus replication by binding to viral coat proteins, preventing capsid formation, and potentially inducing interferon production. Clinical studies show mixed results: some demonstrate reduced cold duration and severity in adults and school-aged children (e.g., from 9 to 7.5 days), decreased antibiotic use, and prophylactic benefits in lowering cold frequency, while others, particularly in children, found no significant efficacy over placebo. It is generally recognized as safe (GRAS) by the FDA, available over-the-counter, with common administration as 10 mg zinc lozenges dissolved orally multiple times daily; adverse effects include bad taste, nausea, mouth irritation, and diarrhea.

Brand names
Cold-Eeze
Other names
ZGGzinc gluconate glycine lozenges
02

Targets

Human rhinovirus capsid protein

Beyond the preview

Go deeper on zinc gluconate + glycine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc gluconate + glycine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call